Back
Innovate Vs. Akero Therapeutics Industry Stock Comparison
Sell
36
VATE
Innovate
Last Price:
$7.40
Seasonality Move:
-11.45%
Buy
57
AKRO
Akero Therapeutics
Last Price:
$45.97
Seasonality Move:
17.51%
Sell
36
Innovate (VATE)
is a Sell
Is Innovate a Buy, Sell or Hold?
-
VATE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
57
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $46.00. The Score for AKRO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VATE Stock Price Chart
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $46.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
VATE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 59.47 | Buy |
Chaikin Money Flow: | 6853 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.97 - 6.81) | Buy |
Bollinger Bands (100): | (5.43 - 10.29) | Sell |
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.37 | Buy |
Relative Strength Index (14 RSI): | 57.29 | Buy |
Chaikin Money Flow: | -3326004 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (39.44 - 45.9) | Buy |
Bollinger Bands (100): | (32.42 - 50.1) | Buy |
VATE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.25 | Buy |
20-day SMA: | 6.4 | Buy |
50-day SMA: | 6.73 | Buy |
200-day SMA: | 6.36 | Buy |
8-day EMA: | 6.49 | Buy |
20-day EMA: | 6.41 | Buy |
50-day EMA: | 6.81 | Buy |
200-day EMA: | 7.18 | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.28 | Buy |
20-day SMA: | 43.22 | Buy |
50-day SMA: | 41.47 | Buy |
200-day SMA: | 35.02 | Buy |
8-day EMA: | 45.06 | Buy |
20-day EMA: | 43.24 | Buy |
50-day EMA: | 42.12 | Buy |
200-day EMA: | 36.66 | Buy |
Innovate Earnings Growth & VATE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and a decrease next year of $0.63 per share.
Innovate Technical Analysis
May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Akero Therapeutics Technical Analysis
May 13 | May 14 | May 15 | May 16 | May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
13 | 14 | 15 | 16 | 19 | 20 | 21 | 22 | 23 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |